137 related articles for article (PubMed ID: 12222711)
1. Non-classical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations.
Ezquieta B; Cueva E; Varela J; Oliver A; Fernández J; Jariego C
Acta Paediatr; 2002; 91(8):892-8. PubMed ID: 12222711
[TBL] [Abstract][Full Text] [Related]
2. Classical and nonclassical 21-hydroxylase deficiency: a molecular study of Argentine patients.
Dain LB; Buzzalino ND; Oneto A; Belli S; Stivel M; Pasqualini T; Minutolo C; Charreau EH; Alba LG
Clin Endocrinol (Oxf); 2002 Feb; 56(2):239-45. PubMed ID: 11874416
[TBL] [Abstract][Full Text] [Related]
3. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Bachega TA; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2000 May; 52(5):601-7. PubMed ID: 10792340
[TBL] [Abstract][Full Text] [Related]
4. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
Speiser PW; New MI
J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
[TBL] [Abstract][Full Text] [Related]
5. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
[TBL] [Abstract][Full Text] [Related]
6. Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests.
Witchel SF; Lee PA
Am J Med Genet; 1998 Apr; 76(4):337-42. PubMed ID: 9545098
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency.
Weintrob N; Brautbar C; Pertzelan A; Josefsberg Z; Dickerman Z; Kauschansky A; Lilos P; Peled D; Phillip M; Israel S
Eur J Endocrinol; 2000 Sep; 143(3):397-403. PubMed ID: 11022183
[TBL] [Abstract][Full Text] [Related]
8. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms.
Rumsby G; Avey CJ; Conway GS; Honour JW
Clin Endocrinol (Oxf); 1998 Jun; 48(6):707-11. PubMed ID: 9713558
[TBL] [Abstract][Full Text] [Related]
10. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
[TBL] [Abstract][Full Text] [Related]
11. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
[TBL] [Abstract][Full Text] [Related]
12. Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers of 21-hydroxylase deficiency.
Napolitano E; Manieri C; Restivo F; Composto E; Lanfranco F; Repici M; Pasini B; Einaudi S; Menegatti E
J Endocrinol Invest; 2011; 34(7):498-501. PubMed ID: 20671415
[TBL] [Abstract][Full Text] [Related]
13. 'Cryptic' form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in the Yugoslav population.
Dumić M; Brkljacić L; Mardesić D; Plavsić V; Lukenda M; Kastelan A
Acta Endocrinol (Copenh); 1985 Jul; 109(3):386-92. PubMed ID: 2992207
[TBL] [Abstract][Full Text] [Related]
14. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women.
Blanché H; Vexiau P; Clauin S; Le Gall I; Fiet J; Mornet E; Dausset J; Bellanné-Chantelot C
Hum Genet; 1997 Nov; 101(1):56-60. PubMed ID: 9385370
[TBL] [Abstract][Full Text] [Related]
15. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Deneux C; Tardy V; Dib A; Mornet E; Billaud L; Charron D; Morel Y; Kuttenn F
J Clin Endocrinol Metab; 2001 Jan; 86(1):207-13. PubMed ID: 11232002
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Russian women with hyperandrogenism.
Grodnitskaya E; Kurtser M
Hum Fertil (Camb); 2018 Dec; 21(4):281-287. PubMed ID: 28669219
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
[TBL] [Abstract][Full Text] [Related]
18. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
19. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne.
Ostlere LS; Rumsby G; Holownia P; Jacobs HS; Rustin MH; Honour JW
Clin Endocrinol (Oxf); 1998 Feb; 48(2):209-15. PubMed ID: 9579234
[TBL] [Abstract][Full Text] [Related]
20. 17-Hydroxyprogesterone in children, adolescents and adults.
Honour JW
Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
